logo
  • About us
    • Reig Jofre in brief
    • Strategic pillars
    • Company history
    • Locations
  • R&D
    • R&D
    • Innovation in Collaboration
    • Pipeline
    • Joint projects
  • Products
    • Healthcare professionals and consumers corner
  • Services
    • CDMO services
    • CMO services
  • Investors
    • Information note
    • General information
    • Inside information
    • Other relevant information
    • Former relevant facts
    • Financial information
    • Corporate governance
    • General shareholders’ meetings
    • The share
    • Analysts covering the stock
    • Presentations
    • Webcasts
  • Press
    • News and repository
    • Reig Jofre in the media (ES)
    • Newsletter
  • Social Responsibility
  • Contact
    • Contact form
    • Work with us
    • Report an adverse effect
  • Ethics channel
  • |
  • ES
  • EN

News

Transparency withour stakeholders

2017
  1. Home
  2. Archive by Category "2017"
  3. (
  4. Page 2
  5. )

25 July 2017

Reig Jofre informs about the new shares

24 July 2017

Transactions within the share buyback program

18 July 2017

Transactions within the share buyback program

10 July 2017

Transactions within the share buyback program

5 July 2017

Transactions within the liquidity contract in Q2 2017

4 July 2017

Reig Jofre informs on the end of the commitments between the Company and Naturex SA

3 July 2017

Reig Jofre informs about its scrip dividend

30 June 2017

Reig Jofre informs about second shares buy-back program

15 June 2017

Begining of the trading period of free allotment rights

8 June 2017

Conditions for the execution of the capital increase through the scrip dividend or flexible dividend

8 June 2017

Resolutions on the general shareholders’ meeting

9 May 2017

Results note: First quarter of 2017

8 May 2017

Convening of the Ordinary and Extraordinary General Shareholders’ Meeting

3 May 2017

Reig Jofre, strategic partner in the stabilization and production of the first recombinant veterinary vaccine against Leishmaniasis, by Laboratorios Leti

6 April 2017

Transactions within the liquidity contract in Q1 2017

30 March 2017

Reig Jofre inaugurates a new analytical laboratory for development and quality control

23 March 2017

Reig Jofre starts marketing of three new injectable products for hospitals

16 March 2017

Reig Jofre joins Ship2B foundation to accompany emerging companies of social impact

28 February 2017

Results preview: Year 2016

23 February 2017

Reig Jofre informs on the public deed of capital reduction

  • 1
  • 2
  • 3

Legal Notice and Terms of Use – Privacy Policy – Cookie policy – Social Media Privacy Policy
Online store access for employees – RJF connected

© 2020 Laboratorio Reig Jofre

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsRead MoreAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
SAVE & ACCEPT

Privacy Preference Center

Privacy Preferences